Psykey, Inc. (OTCMKTS:CEOS) Sees Large Growth in Short Interest

Psykey, Inc. (OTCMKTS:CEOSGet Free Report) was the recipient of a large growth in short interest during the month of January. As of January 15th, there was short interest totalling 6,100 shares, a growth of 154.2% from the December 31st total of 2,400 shares. Based on an average trading volume of 2,092,600 shares, the short-interest ratio is presently 0.0 days.

Psykey Stock Performance

Shares of Psykey stock traded down $0.00 during trading on Friday, hitting $0.02. 334,873 shares of the stock traded hands, compared to its average volume of 1,147,083. The stock’s fifty day simple moving average is $0.03 and its 200 day simple moving average is $0.03. Psykey has a 52-week low of $0.01 and a 52-week high of $0.04.

Psykey Company Profile

(Get Free Report)

Psykey, Inc engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines to improve and optimize life. The company also engages in the development of technologies for the composition, bioavailability, and targeted delivery of entheogen-based therapeutics for the psychedelic market.

Featured Stories

Receive News & Ratings for Psykey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Psykey and related companies with MarketBeat.com's FREE daily email newsletter.